S&P/ASX All Ords Index (ASX: XAO) shares are down 3% over 12 months.
On The Bull this week, Mark Gardner from MPC Markets shares his insights on three stocks.
Greatland Resources Ltd (ASX: GGP)
The Greatland Resources share price is up 40% over 12 months.
Gardner has a buy call on this ASX gold mining share.
He said:
Greatland is moving into mid-tier gold and copper production.
GGP produced 328,987 ounces of gold and 14,594 tonnes of copper in full year 2026. The company beat production and cost guidance.
Net profit after tax of $862 million was up 156 per cent on the prior corresponding period.
The shares have fallen on weaker production guidance in full year 2027.
GGP offers an appealing entry price. In our view, the market is too focused on a weaker guidance rather than funded growth.
Telix Pharmaceuticals Ltd (ASX: TLX)
The Telix Pharmaceuticals share price is up 7% over 12 months.Â
Gardner has a hold rating on this ASX healthcare share.Â
He explained:Â
The US Food and Drug Administration recently approved the company’s brain cancer imaging drug Pixclara.
TLX shares soared on the news, but we believe the approval is largely priced in at this point.
However, the underlying business is in good shape. Group revenue of $US477 million in the first half of 2026 was up 22 per cent on the prior corresponding period.
The group gross margin of 55 per cent was up 2 per cent year-on year. The company maintained a cash balance of $US252 million at June 30, 2026.
Qualitas Ltd (ASX: QAL)
The Qualitas share price is down 34% over 12 months.
Gardner has a sell recommendation on this ASX financial share.
He commented:
Qualitas is an alternative real estate investment manager with about $11.6 billion of committed funds under management at June 30, 2026.
QAL manages investments across real estate private credit and real estate private equity via a range of investment solutions for institutional, wholesale and retail clients.
The company has exposure to construction lending in a sector we believe is under pressure from rising costs amid potentially higher interest rates.
The shares have fallen from $3.36 on August 13 to trade at $2.38 on September 24.
We would rather be on the sidelines until credit costs stop rising.
The post Buy, hold, sell: Telix Pharmaceuticals, Qualitas, Greatland Resources shares appeared first on The Motley Fool Australia.
Should you invest $1,000 in Qualitas right now?
Before you buy Qualitas shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Qualitas wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 1 August 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- These are the 10 most shorted ASX shares
- 2 ASX shares UBS says could increase 13% to 37%
- 5 ASX 200 shares upgraded by experts this week
- Buy, hold, sell: New Hope, REA, Telix Pharmaceuticals shares
- 5 buy-rated shares in the ASX real estate sector to consider
Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Telix Pharmaceuticals. The Motley Fool Australia has recommended Qualitas and Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.